Tags: fda | weight loss | diabetes | prescription | fake | drugs

FDA Chief Very Concerned About Fake Weight Loss Drugs

FDA Chief Very Concerned About Fake Weight Loss Drugs
(Dreamstime)

Wednesday, 28 February 2024 11:11 AM EST

U.S. Food and Drug Administration Commissioner Dr. Robert Califf said Wednesday he is very concerned about the prevalence of compounded and fake versions of highly in demand new weight loss drugs online.

Consumers seeking these medicines are attracted to compounded versions that are sold without proper controls to ensure they get the right active drug, Califf said in a Reuters Newsmaker interview.

"In the context of the total picture of illicit drugs being sold on the internet, it's almost certainly bigger than, much bigger than what we see," he said of such reports to the agency.

Califf said he is also concerned about the "enormous disparity" between people who can get access to the new drugs for weight loss based on wealth or connections to the medical community, and those who do not have those advantages but might have a greater need for the treatments.

Some analysts have forecast the market for weight-loss drugs, currently led by Novo Nordisk's Wegovy and Eli Lilly's Zepbound and Mounjaro, could reach $100 billion a year by the end of the decade.

Earlier this month, the FDA sent warning letters to two online vendors for selling unapproved and misbranded versions of semaglutide and tirzepatide, the active ingredients Wegovy and Zepbound, respectively.

© 2024 Thomson/Reuters. All rights reserved.


StreetTalk
U.S. Food and Drug Administration Commissioner Dr. Robert Califf said Wednesday he is very concerned about the prevalence of compounded and fake versions of highly in demand new weight loss drugs online.
fda, weight loss, diabetes, prescription, fake, drugs
207
2024-11-28
Wednesday, 28 February 2024 11:11 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved